Pieter Proot

642 total citations
12 papers, 454 citations indexed

About

Pieter Proot is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Pieter Proot has authored 12 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in Pieter Proot's work include Diabetes Treatment and Management (7 papers), Diabetes Management and Research (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). Pieter Proot is often cited by papers focused on Diabetes Treatment and Management (7 papers), Diabetes Management and Research (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). Pieter Proot collaborates with scholars based in Switzerland, United States and Belgium. Pieter Proot's co-authors include Michael Stümvoll, Stefano Del Prato, David R. Matthews, Päivi M. Paldánius, YannTong Chiang, Peter de Witte, Ann L. Vandenbogaerde, Wilfried Merlevede, Plamen Kozlovski and Deborah Keefe and has published in prestigious journals such as The Lancet, Transplantation and Obesity.

In The Last Decade

Pieter Proot

12 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pieter Proot Switzerland 8 270 191 91 81 47 12 454
C. H. L. Shackleton United States 10 352 1.3× 148 0.8× 65 0.7× 24 0.3× 62 1.3× 14 585
Xinyu Shao China 10 120 0.4× 204 1.1× 90 1.0× 21 0.3× 33 0.7× 25 439
Xiaoming Ye China 12 58 0.2× 151 0.8× 65 0.7× 61 0.8× 26 0.6× 25 373
Roberta Avvisato Italy 10 90 0.3× 120 0.6× 53 0.6× 44 0.5× 77 1.6× 20 352
Qin Huang China 11 75 0.3× 108 0.6× 83 0.9× 15 0.2× 30 0.6× 19 368
Monika Malm-Erjefält Sweden 10 138 0.5× 108 0.6× 79 0.9× 59 0.7× 159 3.4× 10 403
U Seiffert Germany 11 107 0.4× 143 0.7× 66 0.7× 47 0.6× 32 0.7× 29 377
Susan Andrews United States 9 122 0.5× 103 0.5× 78 0.9× 51 0.6× 89 1.9× 20 368
Shinichi Abe Japan 13 59 0.2× 117 0.6× 86 0.9× 36 0.4× 45 1.0× 38 459
Nishan Guha United Kingdom 12 181 0.7× 136 0.7× 16 0.2× 20 0.2× 40 0.9× 31 382

Countries citing papers authored by Pieter Proot

Since Specialization
Citations

This map shows the geographic impact of Pieter Proot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pieter Proot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pieter Proot more than expected).

Fields of papers citing papers by Pieter Proot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pieter Proot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pieter Proot. The network helps show where Pieter Proot may publish in the future.

Co-authorship network of co-authors of Pieter Proot

This figure shows the co-authorship network connecting the top 25 collaborators of Pieter Proot. A scholar is included among the top collaborators of Pieter Proot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pieter Proot. Pieter Proot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Vencio, Sérgio, et al.. (2021). Exploring early combination strategy in Latin American patients with newly diagnosed type 2 diabetes: a sub-analysis of the VERIFY study. Diabetology & Metabolic Syndrome. 13(1). 68–68. 1 indexed citations
2.
Bays, Harold, Plamen Kozlovski, Qing Shao, Pieter Proot, & Deborah Keefe. (2020). Licogliflozin, a Novel SGLT1 and 2 Inhibitor: Body Weight Effects in a Randomized Trial in Adults with Overweight or Obesity. Obesity. 28(5). 870–881. 32 indexed citations
3.
Boer, Rudolf A. de, et al.. (2020). Effects of the dual sodium–glucose linked transporter inhibitor, licogliflozin vs placebo or empagliflozin in patients with type 2 diabetes and heart failure. British Journal of Clinical Pharmacology. 86(7). 1346–1356. 35 indexed citations
4.
Yoo, Soon Jib, Sang‐Ah Chang, Tae Seo Sohn, et al.. (2020). Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus. Diabetes & Metabolism Journal. 45(6). 954–959. 1 indexed citations
5.
6.
Matthews, David R., Päivi M. Paldánius, Michael Stümvoll, et al.. (2019). A pre‐specified statistical analysis plan for the VERIFY study: Vildagliptin efficacy in combination with metformin for early treatment of T2DM. Diabetes Obesity and Metabolism. 21(10). 2240–2247. 7 indexed citations
7.
Matthews, David R., Päivi M. Paldánius, Pieter Proot, et al.. (2018). Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin‐metformin combination in newly diagnosed Type 2 diabetes. Diabetic Medicine. 36(4). 505–513. 10 indexed citations
8.
Hoitsma, Andries J., E. Steve Woodle, Daniel Abramowicz, Pieter Proot, & Yves Vanrenterghem. (2011). FTY720 combined with tacrolimus in de novo renal transplantation: 1-year, multicenter, open-label randomized study. Nephrology Dialysis Transplantation. 26(11). 3802–3805. 33 indexed citations
9.
Kovarik, John M., Jürg Steiger, Josep M. Grinyó, et al.. (2010). Pharmacokinetics of Sotrastaurin Combined With Tacrolimus or Mycophenolic Acid in De Novo Kidney Transplant Recipients. Transplantation. 91(3). 317–322. 11 indexed citations
10.
Proot, Pieter, et al.. (1998). Stability of adenosine in infusion. Journal of Pharmaceutical and Biomedical Analysis. 17(3). 415–418. 1 indexed citations
11.
Vandenbogaerde, Ann L., et al.. (1997). Differential cytotoxic effects induced after photosensitization by hypericin. Journal of Photochemistry and Photobiology B Biology. 38(2-3). 136–142. 90 indexed citations
12.
Himpens, Bernard, Pieter Proot, Johan Neyts, et al.. (1995). Human cytomegalovirus modulates the Ca2+ response to vasopressin and ATP in fibroblast cultures. Cell Calcium. 18(2). 111–119. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. H. L. Shackleton Breakdown of academic impact, for papers by Xinyu Shao Breakdown of academic impact, for papers by Xiaoming Ye Breakdown of academic impact, for papers by Roberta Avvisato Breakdown of academic impact, for papers by Qin Huang Breakdown of academic impact, for papers by Monika Malm-Erjefält Breakdown of academic impact, for papers by U Seiffert Breakdown of academic impact, for papers by Susan Andrews Breakdown of academic impact, for papers by Shinichi Abe Breakdown of academic impact, for papers by Nishan Guha
Rankless by CCL
2026